{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:07:18Z","timestamp":1761523638723,"version":"3.41.2"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1111\/igc.0b013e31819a1fa5","type":"journal-article","created":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T13:20:11Z","timestamp":1291382411000},"page":"261-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["A Clinical and Biological Comparison Between Malignant Mixed M\u00fcllerian Tumors and Grade 3 Endometrioid Endometrial Carcinomas"],"prefix":"10.1016","volume":"19","author":[{"given":"Amy E.","family":"Bland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cara","family":"Heuser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfen","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Jazaeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Shutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurel","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0005","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ygyno.2004.08.019","article-title":"Prognosis of papillary serous, clear cell and grade 3 stage I carcinoma of the endometrium","volume":"95","author":"Creasman","year":"2004","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0010","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0360-3016(03)01561-X","article-title":"Malignant mixed mullerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome","volume":"58","author":"Callister","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0090-8258(03)00332-9","article-title":"A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed mullerian tumors with evaluation of potential molecular targets","volume":"90","author":"Ramondetta","year":"2003","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0020","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/ijgc-00009577-200211000-00001","article-title":"Uterine carcinosarcomas (malignant mixed mu\u00a8 llerian tumors) are metaplastic cardinomas","volume":"12","author":"McCluggage","year":"2002","journal-title":"Int J Gynecol Cancer."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0025","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1200\/JCO.2004.02.088","article-title":"Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study","volume":"22","author":"Thigpen","year":"2004","journal-title":"J Clin Oncol."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0030","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1200\/JCO.2001.19.20.4048","article-title":"Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study","volume":"19","author":"Hoskins","year":"2001","journal-title":"J Clin Oncol."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0035","first-page":"1364","article-title":"Combined adjuvant cisplatin and ifosfamide chemotherapy and radiotherapy for malignant mixed mullerian tumors of the uterus","volume":"16","author":"Wong","year":"2006","journal-title":"Int J Gynecol Cancer."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0040","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/0360-3016(86)90011-8","article-title":"Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma","volume":"12","author":"Hornback","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0045","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0360-3016(96)00486-5","article-title":"Primary treatment of endometrial carcinoma with high dose rate brachytherapy: results of 12 years of experience with 280 patients","volume":"37","author":"Knocke","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0050","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00004347-200010000-00003","article-title":"The molecular biology of endometrial tumorigenesis: does it have a message?","volume":"19","author":"Ellenson","year":"2000","journal-title":"Int J Gynecol Pathol."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0055","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ajog.2005.12.020","article-title":"Biologic targets for therapeutic intervention in endometrioid endometrial adenocarcinoma and malignant mixed mullerian tumors","volume":"194","author":"Rice","year":"2006","journal-title":"Am J Obstet Gynecol."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0060","doi-asserted-by":"crossref","first-page":"9994","DOI":"10.1074\/jbc.273.16.9994","article-title":"Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells","volume":"273","author":"Jackson","year":"1998","journal-title":"J Biol Chem."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF02505331","article-title":"Immunohistochemically detected HER-2\/neu-expression and prognosis in endometrial carcinoma","volume":"259","author":"Backe","year":"1997","journal-title":"Arch Gynecol Obstet."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ygyno.2005.07.124","article-title":"EGFR expression and HER-2\/neu overexpression\/amplification in endometrial carcinosarcoma","volume":"100","author":"Livasy","year":"2006","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0075","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ygyno.2005.04.027","article-title":"Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer","volume":"98","author":"Amant","year":"2005","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0080","unstructured":"Surveillance Epidemiology, and End Results (SEER) Program, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 2006, http:\/\/ seer.cancer.gov."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0085","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/aje\/kwk010","article-title":"Racial\/ethnic differences in endometrial cancer risk: the multiethnic cohort study","volume":"165","author":"Setiawan","year":"2007","journal-title":"Am J Epidemiol."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0090","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1200\/JCO.2006.06.4907","article-title":"Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a gynecologic oncology group study","volume":"25","author":"Homesley","year":"2007","journal-title":"J Clin Oncology."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.pai.0000129057.38941.a1","article-title":"Imatinib mesylate (Gleevec)Ytargeted kinases are expressed in uterine sarcomas","volume":"13","author":"Caudell","year":"2005","journal-title":"Appl Immunohistochem Mol Morphol."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0100","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0046-8177(99)90043-6","article-title":"Angiogenesis in carcinosarcoma of the uterus: differences in the microvessel density and expression of vascular endothelial growth factor between the epithelial and mesenchymal elements","volume":"30","author":"Emoto","year":"1999","journal-title":"Hum Pathol."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0105","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004347-199004000-00004","article-title":"Prognostic factors for malignant mixed mullerian tumors of the uterus","volume":"9","author":"Schweizer","year":"1990","journal-title":"Int J Gynecol Pathol."},{"key":"10.1111\/IGC.0b013e31819a1fa5_bb0110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/gyno.1996.0015","article-title":"The expression of epidermal growth factor receptor, HER-2\/Neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma","volume":"60","author":"Swisher","year":"1996","journal-title":"Gynecol Oncol."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2FIGC.0b013e31819a1fa5","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24026811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24026811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1111\/IGC.0b013e31819a1fa5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:08:04Z","timestamp":1753232884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24026811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S1048891X24026811"],"URL":"https:\/\/doi.org\/10.1111\/igc.0b013e31819a1fa5","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Clinical and Biological Comparison Between Malignant Mixed M\u00fcllerian Tumors and Grade 3 Endometrioid Endometrial Carcinomas","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/IGC.0b013e31819a1fa5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}